Brief: Cytomx Therapeutics Inc Does Not Consider Its Exposure To Any Liquidity Concern At SVB To Be Significant
10/03/2023 23:14
March 10 (Reuters) - CytomX Therapeutics Inc CTMX.O :
* CYTOMX THERAPEUTICS INC - CYTOMX DOES NOT CONSIDER ITS
EXPOSURE
TO ANY LIQUIDITY CONCERN AT SVB TO BE SIGNIFICANT
* CYTOMX THERAPEUTICS INC - CASH HELD AT SVB IN CYTOMX’S
OPERATING ACCOUNT IS AT OR NEAR THE FDIC-INSURED LIMIT OF
$250,000
Source: (shorturl.at/enK78)
Further company coverage: CTMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway